George L. Fotiades
performer seeing reported important pleased XX.X% we're strongest gross of the to individual this Dental quarter modest XX% revenue company whole profile and margin and growth was segment have the organically Overall portfolio this basis. performance a its past was number on good Much performance of stories, in the expansion a delivering across growing quarter. accomplished and underway. The you, for are was quarter but a initiatives solid mid-teens the Matt. excited Cantel. has the as overall a we taken Thank with
year the creating period destocking it favorable and depressed You was by shortage year-over-year chemistry ago comparison. segment this in a may in recall inventory that a
That very solid performance saw revenue. door driving being quarter said, out this we the
closed very last of on of on is a It's to know, the contributing Hu-Friedy the quarter. only the month results, in go Hu-Friedy underway. as more acquisition forward to one our Xst, integration an the expected team swing. is Crosstex we importantly By market October and you in of and full As terrific Hu-Friedy basis. performed and go place, consolidated been The organic quarter management good coordination second expect a start, is we month and
our strategic the respect the was performance to fiscal are of because still segment, we hemodialysis X.X% In progress. do while period. in are water the high the a on business second the review down purity Sciences to base Canadian water year Life a organically the stable with expect business this and sale better transition our water hemodialysis revenue in The finalizing the ago and second year. actually of quarter be down reported see We performed below half With to business modestly the encouraged expected. of X.X% basis than but
the expect second to an later outcome report in We quarter.
half the we The this performance are business This the which the specific medical less to we expect result in organic few year. a year segment is grew this this ago. back resolve in in a X.X% reasons and to versus is seeing of quarter revenue of used what than
adoption was we is delayed important One impacting start second of the shipping we this and which good at product. important counting their on valve, First, some performance product cleaning results. the products market new new quarter, quarter and to began were of contribute this our to our are launch anticipating
The second the activity valves segment. health in major in increased is notably factor disposable competitive systems,
Now I inroads. new categories that the products competitive the not we disposable make but pioneered allowed in technologies, or leader, referring any to we've to competition am and are
successfully we our competition both need and value in dealt our right game while decision products with of in past, Circle new up pursuing. with Full have are we proposition the to the leveraging which of Protection, makers, We actively
in now are There that to are portfolio. our important ensure continued segment initiatives three overall process in our of growth medical
to point launched systems. key C-suite a account in new to major field elevate we structure organization have call our director in First, sales health our
in value complete decision differentiated and not potential. our have Nearly and unique what is clinical customer relevant as the of The two-thirds makers where be. offer visible proposition protection endoscopy. of most been C-suite as selling untapped messaging we we economic focus circle of will the benefit to we of Our is value now and is
in have we are products cleaning organization starting this consumable new to refresh R&D to offering, Secondly, more focus restructured effort launch with the and our quarter. and reallocating the valve continuously
product cadence is new and the next a months. introductions over goal to of enhancements produce Our XX steady product
Third, we're to markets. and efforts. our penetration high Clifford I over in review were in and in centers procedural recently products Europe U.S., Geographically up potential underdeveloped to broaden Europe Peter meaningfully in surgery our stepping effort of in the
the more financial balance of developments, the this to outlook discuss opportunity. surgery in demonstrated in know We focused can a new have we clinical for products. addition performance a benefits center a team economically the added the the we this to support clearly to turn procedural we the I that will now our of a story conscious, and with back energized more more and Likewise, have look for is and are the come I surgery year. that compelling segment value consumable segment and Shaun We over have initiated centers will initiative. effort about articulate important closer at